Clinical Trials Insight: 700024039
Phase of Trial: Phase II
Latest Information Update: 26 Jan 2010
At a glance
- Drugs Bafetinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Registrational; Therapeutic Use
- Sponsors INNOVIVE Pharmaceuticals
- 26 Jan 2010 Status changed from planning to unconfirmed.
- 22 Jun 2007 New trial record.